Marketing-authorisation holder
Shine Europe B.V.
3 medicines in 3 countries, as authorisation holder.
Group structure
Part of
ShinePharmaceutical groupOther companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Ilumira | Lutetium | EU (EMA) | Authorised | 2026 |
| ILUMIRAPrecursore radiofarmaceutico | Lutezio | Italy | Authorised | |
| Ilumira 37 GBq/ml radiofarmaceutische uitgangsstof, oplossingRadiofarmaceutische uitgangsstof | Lutetium(177 lu)oxodotreotide | Netherlands | Authorised | 2026 |